Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study
Clinical trial NCT02433340 · COMPLETED
Trial details
- NCT number
- NCT02433340
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.